Quest Diagnostics Inc (DGX) Stock Price Today
Aura AI Summary
Key Stats
- $23.03BMarket Cap
- -Volume
- HealthSector
- $216.0252W High
- $166.4252W Low
- -Typical Hold Time
- $29.04BEnterprise Value
- 1.65%Div Yield
- -Trading Activity
Track Quest Diagnostics Inc (DGX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $166.42 and a high of $216.02, highlighting its annual price range. Buy and sell Quest Diagnostics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Most Recent News
Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...

Alamar Biosciences showcases over 140 presentations on blood-based Alzheimer's biomarkers at AAIC 2026.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...

Meta pauses Instagram AI image feature after privacy backlash
Meta has halted a new AI feature on Instagram that generated images using public account photos without user consent, following widespread privacy and copyright concerns. The feature was automatically enabled for public profiles, sparking criticism f...
